Sentences with phrase «cancer nanotechnology research»
Despite dynamic progress and the rapidly growing community of researchers involved in cancer nanotechnology research, there is still a lot to be accomplished in the field, said Grodzinski.
https://www.rdmag.com/ Not exact matches
With funding from the Alberta Cancer Board, the National Science and Engineering Research Council, the Canadian Institutes of Health Research (CIHR), the Canadian Foundation for Innovation, and the Alberta Innovation and Science Research Investment Program, the University of Alberta (UA) in Edmonton has become a major center of nanotechnology research and has fostered the spin - off and growth of a host of coResearch Council, the Canadian Institutes of Health Research (CIHR), the Canadian Foundation for Innovation, and the Alberta Innovation and Science Research Investment Program, the University of Alberta (UA) in Edmonton has become a major center of nanotechnology research and has fostered the spin - off and growth of a host of coResearch (CIHR), the Canadian Foundation for Innovation, and the Alberta Innovation and Science Research Investment Program, the University of Alberta (UA) in Edmonton has become a major center of nanotechnology research and has fostered the spin - off and growth of a host of coResearch Investment Program, the University of Alberta (UA) in Edmonton has become a major center of nanotechnology research and has fostered the spin - off and growth of a host of coresearch and has fostered the spin - off and growth of a host of companies.
Singapore has shown to be a powerhouse of nanotech research as «it is pouring lots of money into recruiting high - level scientists in nanomedicine and nanotechnology,» says Scott McNeil, who heads the U.S. National Cancer Institute's Nanotechnology Characterization Labnanotechnology,» says Scott McNeil, who heads the U.S. National Cancer Institute's Nanotechnology Characterization LabNanotechnology Characterization Laboratory (NCL).
So when they go back to the classrooms they talk about their own research, their high - tech research of isolating cancer cells to space technology — we've sent students to NASA or they do nanotechnology or, you know physics or chemistry or, you know, you name it, agriculture — and when they go back to their classrooms and talk this over among their peers, more peers get interested.
His research interests include medicinal chemistry, nanotechnology, drug delivery, cell trafficking and molecular imaging for theranostic applications in cancer and Alzheimer's disease (AD).
-- Receipt of a $ 1 million research grant award from the PA Department of Health's CURE program to support development of nanotechnology to deliver cancer - fighting medications directly into cancer cells, work done by Mark Kester, pharmacology.
And cancer research now involves collaborative efforts from researchers in disciplines such as physics, advanced mathematics, structural biology, nanotechnology, and many more, who have introduced new concepts and approaches to studying cancer.
Dr. Vishwanatha's research is in cancer molecular biology, experimental therapeutics and nanotechnology.
Other Institutions also belong to the Campus: the University of Milan; Cogentech, an IFOM - IEO consortium committed to developing leading genomic technologies (nanotechnologies, proteomics, bioinformatics, disease models), the European School of Molecular Medicine (SEMM), that organizes training in emerging sectors of Biomedicine, offering the first European PhDs in Molecular Medicine, Medical Nanotechnologies, Foundations of the Life Sciences and their Ethical Consequences; Genextra, a biotech company whose mission is to develop new therapies against cancer and aging - related disease; Biopolo, a not for profit company involved in the technological transfer of basic research to the prnanotechnologies, proteomics, bioinformatics, disease models), the European School of Molecular Medicine (SEMM), that organizes training in emerging sectors of Biomedicine, offering the first European PhDs in Molecular Medicine, Medical Nanotechnologies, Foundations of the Life Sciences and their Ethical Consequences; Genextra, a biotech company whose mission is to develop new therapies against cancer and aging - related disease; Biopolo, a not for profit company involved in the technological transfer of basic research to the prNanotechnologies, Foundations of the Life Sciences and their Ethical Consequences; Genextra, a biotech company whose mission is to develop new therapies against cancer and aging - related disease; Biopolo, a not for profit company involved in the technological transfer of basic research to the productive system.
Dr. John Lewis's research interests lie in the areas of nanotechnology and imaging as they relate to the development of novel treatments for chronic diseases such as aging and cancer.
Special emphasis is given to research in the areas of integrative neuro - sciences, medical imaging, translational immunology and cancer research, microbiology and infection research, biochemistry and pharmaceutical research, plant molecular biology, geo - and environmental research, astro - and elementary particle physics, quantum physics and nanotechnology, archeology and prehistory, historical science, religion and cultures, language and cognition, media and educational research.
Cancer Institute research highlights include innovative studies to develop individualized approaches for treatment and prevention of lung cancer; collaboration between medical and materials science researchers to develop treatments for various types of leukemia using nanotechnology to target only cancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor develoCancer Institute research highlights include innovative studies to develop individualized approaches for treatment and prevention of lung cancer; collaboration between medical and materials science researchers to develop treatments for various types of leukemia using nanotechnology to target only cancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor develocancer; collaboration between medical and materials science researchers to develop treatments for various types of leukemia using nanotechnology to target only cancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor develocancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor development.
2010 - 2013: Director of the Center for Nanotechnology Innovation, IIT@NEST, Pisa, Italy 2001 - 2010: Director of the Department of Neuroimaging, Glaxo Smith - Kline Research Center, Verona, Italy 1996 - 2001: Lecturer in Magnetic Resonance, Instiute of Cancer Research, University of London, UK.
Specialism: Accelerators, neutron & light sources, Acoustics, Astronomy, cosmology & space science, Atomic & molecular science, Biophysics & bioengineering, Computational science & software engineering, Condensed matter, Defence & aerospace, Earth & environmental science, Education & communications, Electronics & semiconductors, Energy & renewables, Engineering & instrumentation, Materials science, Mathematics & statistics, Medical physics, cancer research & oncology, Metrology & measurement science, Nanotechnology, Neuroscience, Nuclear, fusion & energy, Optics, lasers & photonics, Physical chemistry, Plasma science & technology, Quantum science & technology, Science policy & patents, Technical sales & commercial
Funding for this study was provided by a grant from the North Carolina Triad Chapter of Golfers Against Cancer, a pilot grant from the Carolina Center for Nanotechnology Excellence, and the North Carolina University Cancer Research Fund.
Individual researchers were supported by the National Institutes of Health, National Cancer Institute, the Carolina Center of Nanotechnology Excellence, the University Cancer Research Fund, the Paul Calabresi Development Award for Clinical Oncology (K12).
In an interdisciplinary collaboration, the University of Pennsylvania School of Veterinary Medicine's Working Dog Center (photo above courtesy of University of Pennsylvania), the School of Arts and Science's Department of Physics and Astronomy, Penn Medicine's Division of Gynecologic Oncology, and the Monell Chemical Senses Center have joined together for a research investigation using canine olfaction, along with chemical and nanotechnology analysis, to detect early - stage human ovarian cancer.